company background image
PBP

Probiotec ASX:PBP Stock Report

Last Price

AU$2.23

Market Cap

AU$181.4m

7D

2.3%

1Y

0.5%

Updated

06 Feb, 2023

Data

Company Financials +

PBP Stock Overview

Probiotec Limited engages in the development, manufacture, packing, and sale of pharmaceuticals, consumer health, and fast-moving consumer products in Australia and internationally.

PBP fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance5/6
Financial Health4/6
Dividends2/6

My Notes

New

Notes are coming soon

Probiotec Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Probiotec
Historical stock prices
Current Share PriceAU$2.23
52 Week HighAU$2.42
52 Week LowAU$2.02
Beta0.44
1 Month Change1.36%
3 Month Change3.24%
1 Year Change0.45%
3 Year Change-8.61%
5 Year Change159.30%
Change since IPO93.07%

Recent News & Updates

Recent updates

Probiotec (ASX:PBP) Has Affirmed Its Dividend Of AU$0.02

Feb 28
Probiotec (ASX:PBP) Has Affirmed Its Dividend Of AU$0.02

Shareholder Returns

PBPAU PharmaceuticalsAU Market
7D2.3%-3.6%0.8%
1Y0.5%-29.0%2.2%

Return vs Industry: PBP exceeded the Australian Pharmaceuticals industry which returned -29% over the past year.

Return vs Market: PBP underperformed the Australian Market which returned 2.2% over the past year.

Price Volatility

Is PBP's price volatile compared to industry and market?
PBP volatility
PBP Average Weekly Movement3.9%
Pharmaceuticals Industry Average Movement9.6%
Market Average Movement8.5%
10% most volatile stocks in AU Market15.5%
10% least volatile stocks in AU Market3.4%

Stable Share Price: PBP is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: PBP's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1996n/aWes Stringerhttps://www.probiotec.com.au

Probiotec Limited engages in the development, manufacture, packing, and sale of pharmaceuticals, consumer health, and fast-moving consumer products in Australia and internationally. The company provides contract manufacturing services for solid dose tablets, capsules, and caplets; tablets coating; blister packing; liquids, creams, gels, ointments, and suspensions; powders and powder blending; and sprays, as well as manufactures and packages finished doses. It also offers analytical and stability testing services; new product formulation and production trials, and ongoing research and development services; and packaging options for human and animal nutrition products, as well as manufactures and exports a range of nutraceuticals and functional ingredient raw materials.

Probiotec Limited Fundamentals Summary

How do Probiotec's earnings and revenue compare to its market cap?
PBP fundamental statistics
Market CapAU$181.35m
Earnings (TTM)AU$13.71m
Revenue (TTM)AU$182.33m

13.2x

P/E Ratio

1.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
PBP income statement (TTM)
RevenueAU$182.33m
Cost of RevenueAU$125.09m
Gross ProfitAU$57.24m
Other ExpensesAU$43.53m
EarningsAU$13.71m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.17
Gross Margin31.39%
Net Profit Margin7.52%
Debt/Equity Ratio61.3%

How did PBP perform over the long term?

See historical performance and comparison

Dividends

2.5%

Current Dividend Yield

32%

Payout Ratio